CSPC Pharmaceutical Group Ltd Financials

Market Capitalization HK$92.83 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	20.33
Forward PE	14.52
Price to Sales TTM	HK$3.43
Price to Book MRQ	HK$2.91
Enterprise to Revenue	3.00
Enterprise to EBITDA	13.58

Financial Reports as of Mar. 31, 2024

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2024-03-31
Profit Margin	15.51%
Operating Margin	21.58%
Return on Assets TTM	9.75%
Return on Equity TTM	12.21%

Income Statement

Revenue TTM	HK$29,612,851,901
Revenue per Share TTM	HK$2.32
Quarterly Revenue Growth	-21.90%
Gross Profit TTM	HK$20,268,562,997
EBITDA	HK$6,961,849,000
Net Income to Common TTM	HK$4,591,921,876
Diluted EPS TTM	HK$0.40
Quarterly Earnings Growth YoY	-8.40%

Balance Sheet

Total Cash MRQ	HK$10,006,334,009
Total Cash per Share MRQ	HK$0.80
Total Debt MRQ	HK$
Total Debt to Equity MRQ	1.50
Current Ratio MRQ	2.27
Book Value per Share MRQ	HK$2.80

Cash Flow

Operating Cash Flow TTM	HK$5,168,924,000
Levered Free Cash Flow TTM	HK$4,328,035,000

1093 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	11,482,551,732
Float Shares	7,832,429,023
Avg 10 Volume	179,370,057
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	31.08%
% Held by Institutions	27.24%

Stock Price Summary

Beta	0.78
Fifty Two Week Low	HK$4.27
Fifty Two Week High	HK$9.48
Fifty Two Week Change	25.28%
Day 50 MA	HK$7.08
Day 200 MA	HK$5.59

Dividends and Splits

Forward Annual Dividend Rate	HK$0.20
Forward Annual Dividend Yield	2.45%
Trailing Annual Dividend Rate	HK$0.26
Trailing Annual Dividend Yield	3.19%
Payout Ratio	74.25%
Dividend Date
Ex Dividend Date	2025-06-04
Last Split Factor
Last Split Date	2020-10-16